Search clinical trials for: Sunitinib mFOLFOX6

Total 992 results

Amgen

Completed

PEAK: Panitumumab Plus mFOLFOX6 vs. Bevacizumab Plus mFOLFOX6 for First Line Treatment of Metastatic Colorectal Cancer (mCRC) Patients With Wild-Type Kirsten Rat Sarcoma-2 Virus (KRAS) Tumors

Metastatic Colorectal Cancer | Colorectal Cancer | Rectal Cancer | Colon Cancer

United States, Belgium, Canada, Italy, Germany, Spain
Sun Yat-sen University

Completed

Vitamin C Intravenously With Chemotherapy in Advanced Colorectal Cancer (Vitality)

Colorectal Neoplasms

China
Genome & Company
Merck Sharp & Dohme LLC

Recruiting

GEN-001 Plus Pembrolizumab for Patients With Advanced Refractory Biliary Tract Cancer

Biliary Tract Cancer

Korea, Republic of
Simcere Pharmaceutical Co., Ltd
The Affiliated Changzhou Tumor Hospital of Suzhou University

Unknown

FOLFOX4 Combined With Endostar in Patients With Advanced Colorectal Cancer

Colorectal Neoplasms

China
IntegraGen SA
Federation Francophone de Cancerologie Digestive; Exystat

Completed

PETACC-8 miR-31-3p and miR-31-5p Ancillary Study

Colorectal Cancer
Yonsei University

Completed

A Trial of Neoadjuvant FOLFOX6 With Short Course Radiotherapy in Patients With Unresectable Rectal Cancer and Liver Metastasis

Rectal Cancer

Korea, Republic of
University Hospital, Essen

Recruiting

Phase Ib/II Single-arm Study of mFOLFOX6, Bevacizumab and Atezolizumab in Advanced Biliary Tract Cancer (COMBATBIL)

Biliary Tract Cancer

Spain, Germany
NewLink Genetics Corporation

Completed

CRLX101(NLG207) in Combination With Bevacizumab for Metastatic Renal Cell Carcinoma (mRCC) Versus Standard of Care (SOC)

Metastatic Renal Cell Carcinoma

Korea, Republic of, United States
Institut für Klinische Krebsforschung IKF GmbH...

Active, not recruiting

Modified FOLFOX Plus/Minus Nivolumab and Ipilimumab vs. FLOT Plus Nivolumab in Patients With Previously Untreated Advanced or Metastatic Gastric Cancer

GastroEsophageal Cancer | Adenocarcinoma of the Stomach

Germany
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Fudan University

Unknown

A Phase I Study of Subutinib Maleate Capsules on Toleration and Pharmacokinetics

Solid Tumor

China
RayzeBio, Inc.

Active, not recruiting

Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy (ACTION-1)

Neuroendocrine Tumors | Carcinoid Tumor | Gastroenteropancreatic Neuroendocrine Tumor | Carcinoid | GEP-NET | Gastroenteropancreatic Neuroendocrine Tumor Disease | Pancreatic NET

Canada, Spain, United States, Netherlands, Belgium, France, Brazil
Sanofi

Completed

Study Comparing Radiochemotherapy With Folfox 4 Regimen or 5FU-Cisplatin in Patients With Inoperable Esophageal Cancer

Esophageal Neoplasms

France
Guangxi Medical University

Unknown

Study of Folfox4 Chemotherapy Regimen to Prevent Early Postoperative Recurrence for HCC-PVTT Patients

Carcinoma, Hepatocellular
Alethia Biotherapeutics

Recruiting

Sotevtamab (AB-16B5) Combined With FOLFOX as Neoadjuvant Treatment Prior to Resection of Colorectal Cancer Liver Metastasis (EGIA-003)

Metastatic Colorectal Cancer

Canada
Chung-Ang University

Completed

BReast CAncer Genes(BRCA) Expressions in Metastatic Gastric Cancer

BRCA Gene Rearrangement

Korea, Republic of
Sun Yat-sen University

Completed

Phase II Trial of Sorafenib Combined With Concurrent HAIC for Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
GlaxoSmithKline

Completed

Study On Pazopanib When Given With FOLFOX6 (Fluorouracil, Oxaliplatin, Leucovorin) Or CapeOx (Capecitabine, Oxaliplatin)

Neoplasms, Colorectal

India, United Kingdom
Centre Hospitalier Universitaire Dijon

Recruiting

Trial Evaluating Modified FOLFIRINOX and Modified FOLFOX in the Treatment of Locally Advanced or Metastatic Small Bowel Adenocarcinoma (FOLFORINOX SBA)

Locally Advanced or Metastatic Small Bowel Adenocarcinoma

France
Pfizer

Completed

A Retrospective Medical Record Review of First-Line Sunitinib Administration Schedules and Outcomes Among Patients With mRCC in Latin America (LA)

Metastatic Renal Cell Carcinoma ( mRCC)

Ecuador, Argentina, Brazil, Colombia
Seoul National University Hospital
SMG-SNU Boramae Medical Center

Completed

A Study of Sunitinib in Patients With Metastatic or Recurrent Thymic Carcinoma (KOSMIC)

Thymic Carcinoma

Korea, Republic of
Eli Lilly and Company

Completed

Atomoxetine Versus Placebo in Children With Attention Deficit/Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder

Japan
Sun Yat-sen University

Unknown

Phase II Study of HAIC Using Cisplatin,Leucovorin and 5-Fluorouracil

HepatoCellular Carcinoma

China
Cantargia AB

Completed

A Phase 1/2 Study of CAN04 in Combination With Different Chemotherapy Regimens in Subjects With Advanced Solid Tumors

Colorectal Cancer | Non Small Cell Lung Cancer | Advanced Solid Tumors | Biliary Tract Cancer

Spain, France
Fudan University

Unknown

Preoperative Transhepatic Arterial Chemotherapy (TAC) in the Treatment of Liver Metastasis of Resectable Colorectal Cancer

Colorectal Cancer

China
Teligene US

Recruiting

A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC

Non-small Cell Lung Cancer

United States
Grupo Espanol de Investigacion en Sarcomas

Recruiting

Trial of Sunitinib and/or Nivolumab Plus Chemotherapy in Advanced Soft Tissue and Bone Sarcomas (ImmunoSarc)

Soft Tissue Sarcoma | Bone Sarcoma

Spain, United Kingdom, Italy
National Cancer Institute (NCI)

Completed

Sunitinib Malate in Treating Patients With Unresectable or Metastatic Kidney Cancer or Other Advanced Solid Tumors

Clear Cell Renal Cell Carcinoma | Recurrent Renal Cell Carcinoma | Stage III Renal Cell Cancer | Stage IV Renal Cell Cancer | Adult Solid Neoplasm

United States
Sun Yat-sen University

Completed

HAIC Versus TACE for Large and Unresectable Hepatocellular Carcinoma Staged BCLC A/B

Hepatocellular Carcinoma

China
Institut für Klinische Krebsforschung IKF GmbH...
Sanofi; Trium Analysis Online GmbH; STABIL - Statistische und Biometrische Lösungen

Completed

Aflibercept and 5-FU vs. FOLFOX as 1st Line Treatment for Elderly or Frail Elderly Patients With Met. Colorectal Cancer (ELDERLY)

Colorectal Cancer

Germany
University of Washington
National Cancer Institute (NCI)

Completed

Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer

Inflammatory Breast Cancer | Male Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer

United States
Fudan University

Completed

Postoperative Folfox4 Only Versus Folfox4 Plus Transhepatic Arterial Chemotherapy (TAC) in the Treatment Unresectable Liver Metastasis of Colorectal Cancer

Unresectable Liver Metastasis of Colorectal Cancer

China
Tesaro, Inc.
GlaxoSmithKline

Completed

Study of TSR-033 With an Anti-programmed Cell Death-1 Receptor (PD-1) in Participants With Advanced Solid Tumors (CITRINO)

Neoplasms

United States, France
Henry Ford Health System

Completed

Phase II Study of Chemo-Radiotherapy in Patients With Resectable and Borderline Resectable Pancreatic Cancer

Pancreas Neoplasm Malignant Resectable

United States
Central European Cooperative Oncology Group

Completed

Safety and Efficacy of Folfox4 + Weekly Cetuximab vs Folfox 4+Biweekly Cetuximab by Metastatic Colorectal Cancer (CORE 2)

Colorectal Cancer

Israel, Austria, Croatia, Greece, Serbia, Bosnia and Herzegovina, Bulgaria, Estonia, Hungary, Latvia, Romania, Slovakia, Slovenia
State University of New York at Buffalo

Not yet recruiting

Study to Evaluate the Safety and Efficacy of Bicalutamide in Combination With Sunitinib in Patients With TKIs-resistant RCC

Carcinoma, Renal Cell
M.D. Anderson Cancer Center
Bristol-Myers Squibb; Pfizer; Janssen Scientific Affairs, LLC

Completed

Maximal Androgen Depletion Followed by Randomization of Maximal Androgen Ablation With Molecular Targeted Therapies

Prostate Cancer

United States
M.D. Anderson Cancer Center

Completed

Bevacizumab in Multiple Phase I Combinations

Advanced Cancer

United States
National University Hospital, Singapore

Unknown

Dose-dense Doxorubicin/Cyclophosphamide With Intermittent Low-dose Sunitinib in Breast Cancer Patients

Breast Cancer

Singapore
Pfizer

Completed

Study Of FOLFIRI Chemotherapy With Or Without Sunitinib In Patients With Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

Belgium, Bulgaria, Hungary, Spain, Ukraine, Germany, Ireland, Korea, Republic of, Poland, Portugal, Russian Federation, Slovakia, Sweden, Mexico, Serbia, Singapore, Taiwan, Thailand, United Kingdom, Cyprus, Czech Republic, India, Ar... and more
M.D. Anderson Cancer Center
Pfizer

Completed

Sunitinib Malate, Hormone Ablation and Radiation Therapy in Patients With Prostate Cancer

Prostate Cancer

United States
Centre Hospitalier Universitaire Dijon

Not yet recruiting

Personalising and Refining Neo-adjuvant Chemotherapy in Locally Advanced But Resecable Colon Cancer in the Elderly of 70 Years Old or More (FOxTROT2France)

Colon Cancer

France
King Abdullah Medical City

Recruiting

Re-challenge Therapy With Chemotherapy & Panitumumab in Metastatic Colorectal Cancer Patients Treated With an Anti-EGFR (REPAN)

Metastatic Colorectal Cancer

Saudi Arabia
Joon Oh Park

Recruiting

Multi-center, Open-label, Phase 1b Clinical Trial to Evaluate the Safety, Tolerability, and Exploratory Efficacy of TEW-7197 in Combination With FOLFOX in Patients With Metastatic Pancreatic Ductal Adenocarcinoma Who Have Failed First-Line Gemcitabine and Nab-Paclitaxel (MP-PDAC-01)

Metastatic Pancreatic Cancer

Korea, Republic of
iOMEDICO AG
Amgen

Completed

Validation of a New Prognostic Score for Adult Patients With RAS Wild-type mCRC Treated With Vectibix® and FOLFIRI or FOLFOX in First Line (VALIDATE) (VALIDATE)

Metastatic Colorectal Cancer | RAS Wild-type

Germany
Centre Hospitalier Universitaire de Besancon
Pfizer

Active, not recruiting

Study to Assess Various Sunitinib Schedules in Renal Cell Carcinoma (SURF)

Kidney Neoplasms | Metastatic Renal Cell Cancer

France
Cathay General Hospital

Completed

Sunitinib® in Patients With Recurrent Ovarian Clear Cell Carcinoma

Ovarian Cancer | Adverse Effects

Taiwan
Amsterdam UMC, location VUmc

Terminated

Phase II Study of Sunitinib Rechallenge in Patients With Metastatic Renal Cell Carcinoma

Metastatic Renal Cell Carcinoma

Netherlands
GERCOR - Multidisciplinary Oncology Cooperative...

Completed

A Study of Sunitinib in Patients With Advanced Cholangiocarcinoma (SUN-CK)

Unresectable and Advanced Cholangiocarcinoma

France
Krankenhaus Nordwest

Terminated

Trial of Single Agent Sunitinib for Patients With Chemo-refractory Metastatic Melanoma

Chemo-refractory Melanoma

Germany
Medical University Innsbruck
Pfizer

Unknown

SUTENT (SUNITINIB, SU11248)in Patients With Recurrent or Progressive Glioblastoma Multiforme (SURGE01-07)

Glioblastoma Multiforme

Austria, Germany

3

Subscribe